Since its creation, Anteis has greatly increased
the number and form of its partnerships.
For commercial cooperation, Anteis uses three types of partnerships:
- Distribution partnerships: with an independent distributor network in more than 85 countries throughout the world
- Two European subsidiaries: Anteis France and Anteis Germany
- Licensing agreement: in 2004, an agreement was signed between Anteis and Merz Pharmaceuticals in Germany. Merz Pharmaceuticals was then given the following geographic areas: Germany, Switzerland, Austria, Italy, Russia, the United Kingdom and the United States to distribute the Esthélis® injectable devices developed by Anteis under the brand Belotero®.
Anteis has also formed first-class scientific partnerships with:
- Groups of doctors and surgeons from several therapeutic sectors
- Independent or university laboratories, in line with the company’s values of integrity and transparency
Lastly, Anteis ensures, on behalf of pharmaceutical companies, customized development of products and injectable devices based on biopolymer transformation.
recommendprint this page top